Dynamics of viremia in primary HIV-1 infection in Africans: Insights from analyses of host and viral correlates
Abstract
No abstract availableKeywords
Funding Information
- United States Agency for International Development (USAID)
- United States National Institute of Allergy and Infectious Diseases (NIAID) (AI071906, AI064060)
- Fogarty AIDS International Training and Research Program (AITRP) (FIC 2D43 TW001042)
This publication has 54 references indexed in Scilit:
- HLA-B Signal Peptide Polymorphism Influences the Rate of HIV-1 Acquisition but Not Viral LoadThe Journal of Infectious Diseases, 2012
- Viremia Copy-Years Predicts Mortality Among Treatment-Naive HIV-Infected Patients Initiating Antiretroviral TherapyClinical Infectious Diseases, 2011
- Prevention of HIV-1 Infection with Early Antiretroviral TherapyNew England Journal of Medicine, 2011
- Transmitted HIV Type 1 Drug Resistance Among Individuals with Recent HIV Infection in East and Southern AfricaAIDS Research and Human Retroviruses, 2011
- Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based studyThe Lancet, 2010
- Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infectionVirology, 2010
- Copy-Years Viremia as a Measure of Cumulative Human Immunodeficiency Virus Viral BurdenAmerican Journal of Epidemiology, 2009
- Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipientsJournal of Experimental Medicine, 2009
- Adaptation of HIV-1 to human leukocyte antigen class INature, 2009
- KIR-HLA intercourse in HIV diseaseTrends in Microbiology, 2008